These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Vancomycin levels, efficacy, and toxicity. Johnson JR Arch Intern Med; 2007 Jun; 167(11):1207; author reply 1208-9. PubMed ID: 17563035 [No Abstract] [Full Text] [Related]
8. Failure of once-daily vancomycin for staphylococcal endocarditis. Marik PE Pharmacotherapy; 1998; 18(3):650-2. PubMed ID: 9620118 [TBL] [Abstract][Full Text] [Related]
9. Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis. Mergenhagen KA; Pasko MT Ann Pharmacother; 2007 Sep; 41(9):1531-5. PubMed ID: 17652126 [TBL] [Abstract][Full Text] [Related]
10. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. Gopal V; Bisno AL; Silverblatt FJ JAMA; 1976 Oct; 236(14):1604-6. PubMed ID: 989135 [TBL] [Abstract][Full Text] [Related]
11. [Daptomycin for the treatment of infective endocarditis: When do we use it?]. Şimşek Yavuz S Turk Kardiyol Dern Ars; 2017 Jun; 45(4):303-307. PubMed ID: 28595198 [No Abstract] [Full Text] [Related]
12. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment. Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804 [No Abstract] [Full Text] [Related]
13. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Chambers HF Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879 [TBL] [Abstract][Full Text] [Related]
14. Is high minimal inhibitory concentration of vancomycin a predictor of poor response in MRSA infections? Faulhaber G; Zavascki A; Fuchs SC Arch Intern Med; 2007 Jun; 167(11):1206-7; author reply 1208-9. PubMed ID: 17563032 [No Abstract] [Full Text] [Related]
15. Lack of evidence associating nephrotoxicity with low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis. Bruss JB Clin Infect Dis; 2009 Sep; 49(5):806; author reply 807-8. PubMed ID: 19653850 [No Abstract] [Full Text] [Related]
16. [Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment]. Espinosa FJ; Valdés M; Martín-Luengo F; Arribas JP; Albaladejo J; Pérez-Gracia A; García-Henarejos JA; Martínez-Madrid O; García-Alberola A Enferm Infecc Microbiol Clin; 1993 May; 11(5):235-40. PubMed ID: 8324018 [TBL] [Abstract][Full Text] [Related]
17. Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections. Jobson S; Moise PA; Eskandarian R Clin Ther; 2011 Oct; 33(10):1391-9. PubMed ID: 22015328 [TBL] [Abstract][Full Text] [Related]
18. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis. Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM; Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021 [TBL] [Abstract][Full Text] [Related]
19. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Woods CW; Cheng AC; Fowler VG; Moorefield M; Frederick J; Sakoulas G; Meka VG; Tenover FC; Zwadyk P; Wilson KH Clin Infect Dis; 2004 Apr; 38(8):1188-91. PubMed ID: 15095227 [TBL] [Abstract][Full Text] [Related]